OncoRedox
Point-of-care Testing Device for Cancer Detection
Active
Seed
Startup
Or Yehuda
Founded 2022-08
OncoRedox is developing a Point-of-care testing device for cancer detection based on ‘Redox-omics’ analysis of urine samples. The technology is based on biochemical electrodes detecting redox metabolic signature using an AI analysis model.
SectorHealth Tech & Life Sciences
StageSeed
Total raised$890K
Employees2
Founded2022-08
HQOr Yehuda
Confidence72
Sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technology
Artificial IntelligenceBiologicals
Target customers
Healthcare & Life SciencesHealthcareProviders